TWiV 1032: Clinical update with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In his weekly clinical update, Dr. Griffin discusses predicting COVID-19 incidence using wastewater surveillance data, use of wastewater metrics to track COVID-19 in the US, wastewater-based epidemiology predicts COVID-19-induced weekly new hospital admissions in over 150 USA counties, association between duration of SARS-CoV-2 positivity and long COVID, rapid direct detection of SARS-CoV-2 aerosols in exhaled breath at the point of care, effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing progression to severe COVID-19, NIH launching of several phase 2 long-COVID treatment trials.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Predicting COVID-19 incidence using wastewater surveillance data (CDC)
- Use of wastewater metrics to track COVID-19 in the US (JAMA)
- Wastewater-based epidemiology predicts COVID-19-induced new hospital admissions (Nature)
- Association between duration of SARS-CoV-2 positivity and long COVID (JID)
- Rapid direct detection of SARS-CoV-2 aerosols in exhaled breath at the point of care (ACS)
- Effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing COVID-19 progression (Viruses)
- NIH has launched several phase 2 long-COVID treatment trials (NIH)
- Fatigue can shatter a person (Atlantic)
- Contribute to our Floating Doctors fundraiser at PWB
- Letters read on TWiV 1032
- Dr. Griffin's COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]